
Nidsulp Injection
Marketer
Nidus Pharma Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Nidsulp Injection
Nidsulp Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation, thus curbing infection spread. Administration must be solely under a physician's guidance; adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately to your doctor. Seek urgent medical attention for allergic reactions (e.g., rashes, itching, edema, respiratory distress). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Sufficient rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor may order lab tests and imaging to monitor treatment effectiveness.
Uses of Nidsulp Injection
Infections caused by bacteria
Major Benefits of Nidsulp Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Nidsulp Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Nidsulp Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Nidsulp Injection works:
Nidsulp Injection merges Ceftriaxone, a bacterium-fighting antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum's role is to counter bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Nidsulp Injection and alcohol has not been shown to produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The administration of Nidsulp Injection during gestation is typically deemed safe. Preclinical trials using animal models have revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Nidsulp Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Nidsulp Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Nidsulp Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Nidsulp Injection to individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Altering the Nidsulp Injection dosage is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Nidsulp Injection :
Should you forget a scheduled Nidsulp Injection, seek medical advice.
Facts to Know About Nidsulp Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
